Our team of Cell and Gene Therapy professionals bring deep technical expertise to help you tackle the unique challenges of our exciting young field.

FOUNDER & CEO
Founded Dark Horse Consulting in 2014. Over 20 years of experience in CMC leadership of cell and gene therapy companies.
COO & MANAGING PARTNER
Seasoned executive with experience leading a wide range of technical, strategic, business and legal functions.
PRINCIPAL
Cross-functional project leader in biopharmaceutical management of international clinical development, regulatory submissions and development strategy.
PRINCIPAL

Nineteen years of experience in CMC for cell and gene therapies, including technology transfer, process development, quality by design, manufacturing, regulatory and facility design.

PRINCIPAL
Bioengineer with expertise in cell therapy, gene therapy, and combination products. Lean Six Sigma Black Belt.
PRINCIPAL
Veteran process development expert with deep expertise in late stage product processes and a wide diversity of experience, spanning cell therapy, gene therapy, and protein/antibody therapeutics.
PRACTICE EXPERT, INTELLECTUAL PROPERTY
Intellectual property (IP) expert and patent practitioner with over 10 years of combined experience in biologics and cell therapy patent prosecution and IP strategy at various stages of product development and commercialization.
PRACTICE EXPERT, QUALITY
Quality and regulatory scientist with 25+ years of experience providing guidance for successful FDA submissions, technology transfers and validation associated with human cellular and tissue based products, biologics, and medical devices.
SENIOR CONSULTANT
Data-driven engineer and subject matter expert in cell cryopreservation, process optimization, scale-up, and technology transfer of cell therapies and clinical diagnostics.
SENIOR CONSULTANT
Cell and gene therapy scientist with 15 years of experience leading research, preclinical, and process optimization for preclinical and clinical stage development programs in industry and academia.
CONSULTANT
Over eight years of experience in process development, cGMP manufacture, technical writing and project management for leading cell and gene therapy companies and academic labs.
CONSULTANT
12 years of experience in process development, GMP manufacturing and technology transfer of cell and virally-modified cell therapy products.
CONSULTANT
Brings broad engineering expertise to help DHC clients tackle their device design, instrument development, and process engineering challenges throughout their products’ lifecycles.
CONSULTANT
Over 5 years of gene therapy experience, spanning upstream, downstream and analytical process development. Lean Six Sigma Green Belt.
VICE PRESIDENT OF FINANCE & CUSTOMER RELATIONS
Responsible for all Finance functions, contract negotiations, and customer relationship management.  Prior to DHC, she spent 14 years in Finance and Business Management functions at Fortune 500 companies.
EXECUTIVE ASSISTANT
Responsible for a broad range of administrative tasks, including calendar management, travel bookings and expense reporting.  Prior to Dark Horse, held Executive Assistant roles at a range of companies in the software, retail, and health services industries.

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.